跳至主要内容
临床试验/NCT00501917
NCT00501917Unknown2 期

Single Center, Prospective, Randomized, Partly-Double Blinded, Controlled Trial to Assess the Safety and Feasibility of Intracoronary Cell Infusion Mobilized With G-CSF and Darbepoetin and Their Effects on Improvement of Cardiac Function in Patients With Myocardial Infarction: Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Erythropoietin Mobilization and Intra-Coronary Cell Infusion -5-Combination Cytokine Therapy Trial

Seoul National University Hospital2 个研究点 分布在 2 个国家目标入组 116 人开始时间: 2007年3月最近更新:
适应症
相关药物

试验速览

阶段
2 期
入组人数
116
试验地点
2
主要终点
change of left ventricular ejection fraction measured by cardiac MRI

研究概览

简要总结

Combination use of darbepoetin and G-CSF will improve left ventricular systolic function in patients with acute myocardial infarction who receive intracoronary infusion of mobilized peripheral blood stem cell in comparison with patient who treated with conventional measures and who received intracoronary infusion of mobilized peripheral blood stem cell by G-CSF alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
15 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ST elevation acute myocardial infarction
  • < 80years
  • successful revascularization of culprit vessel

排除标准

  • uncontrolled congestive heart failure
  • uncontrolled myocardial ischemia
  • uncontrolled ventricular arrhythmia
  • malignancy
  • serious hematologic disease
  • chronic renal failure

结局指标

主要结局

change of left ventricular ejection fraction measured by cardiac MRI

时间窗: 6, 12, and 24month

次要结局

  • wall motion score index exercise capacity BNP(6,12, 24month)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验